IMMUTOL Kick off meeting on 24th and 25th of May 2023 in Milan

1024 768 IMMUTOL

The IMMUTOL Consortium, led by Silvia Gregori (San Raffaele Telethon Institute for Gene Therapy– SR-TIGET) successfully kicked-off the project at a hybrid event, held at the Fondazione Telethon, Milano (Italy), between 24th and 25th of May.

Thanks to EU Horizon Europe (Grant Agreement Nr.: 101080562) for supporting fast-tracking the development and validation of an Advanced Therapy Medicinal Product based on engineered dendritic cells to treat patients with immune-mediated diseases with an unmet medical need, in particular multiple sclerosis.

Link to LinkedIn post